A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 18 Years and Older With APOL1-mediated Proteinuric Kidney Disease
Lay Description
Category
- Aging and Geriatric
- Urinary Tract and Kidney
- IRB Number
- 20220167HU
- NCT Number
- NCT # not yet entered
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Johnnie Jones
210-450-7277
jonesj21@uthscsa.edu
Lorannys Sanchez Tamarez
210-450-3937
sancheztamar@uthscsa.edu
Principal Investigator
Manoj Bhattarai